Mycophenolate Mofetil 250 mg/1

Mycophenolate Mofetil 250 mg capsules are an immunosuppressant medication used to prevent organ rejection after transplants. This oral medication is manufactured by Camber Pharmaceuticals, Inc. in the USA.

Mycophenolate Mofetil is primarily used to prevent rejection of transplanted organs, such as kidneys, hearts, or livers. It works by suppressing the immune system to reduce the risk of the body attacking the new organ. This medication is often prescribed in combination with other immunosuppressants to enhance effectiveness.

Common effects of Mycophenolate Mofetil may include nausea, vomiting, diarrhea, and stomach pain. Some individuals might experience fatigue, fever, or an increased risk of infections due to its immunosuppressant properties. It is important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Mycophenolate Mofetil should be handled with care, especially by pregnant women or those planning to become pregnant, as it can cause harm to an unborn baby. It is crucial to follow the prescribed dosage and avoid abrupt discontinuation without medical advice. Regular blood tests may be required to monitor for potential side effects.

Mycophenolate Mofetil can interact with various medications, including antacids, oral contraceptives, and other immunosuppressants. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be minimized, as it may exacerbate certain side effects.